Alibaba Health Information Technology Limited
DB:TWY Rapport sur les actions
Capitalisation boursière : €8.1b
Alibaba Health Information Technology Bilan de santé
Santé financière contrôle des critères 6/6 Alibaba Health Information Technology possède un total de capitaux propres de CN¥14.5B et une dette totale de CN¥0.0, ce qui porte son ratio d'endettement à 0%. Son actif total et son passif total sont CN¥19.7B et de CN¥5.2B. L'EBIT de Alibaba Health Information Technology est CN¥637.4M ce qui fait que son ratio de couverture des intérêts -1.3. Elle dispose de liquidités et de placements à court terme de CN¥9.6B.
Informations clés Ratio de couverture des intérêts -1.3x Argent liquide CN¥9.55b Fonds propres CN¥14.52b Total du passif CN¥5.19b Total des actifs CN¥19.71b
Mises à jour récentes de la santé financière
Afficher toutes les mises à jour
Alibaba Health Information Technology Limited to Report First Half, 2025 Results on Nov 13, 2024 Nov 02
Full year 2024 earnings released: EPS: CN¥0.063 (vs CN¥0.04 in FY 2023) Jul 31
Alibaba Health Information Technology Limited, Annual General Meeting, Aug 30, 2024 Jul 30
New major risk - Share price stability Jun 04
Full year 2024 earnings released: EPS: CN¥0.063 (vs CN¥0.04 in FY 2023) May 28
Alibaba Health Information Technology Limited to Report Fiscal Year 2024 Results on May 27, 2024 May 16
New minor risk - Share price stability Feb 16
New minor risk - Shareholder dilution Jan 18
First half 2024 earnings released: EPS: CN¥0.033 (vs CN¥0.012 in 1H 2023) Nov 29
Alibaba Health Information Technology Limited Announces Executive Changes Nov 29
Alibaba Health Information Technology Limited to Report First Half, 2024 Results on Nov 28, 2023 Nov 17
Alibaba Health Information Technology Limited Appoints Xu Haipeng as Non-Executive Director Oct 20
Less than half of directors are independent Aug 17
Alibaba Health Information Technology Limited Announces Executive Changes and Committee Changes Aug 12
Full year 2023 earnings released: EPS: CN¥0.04 (vs CN¥0.02 loss in FY 2022) Jul 14
Alibaba Health Information Technology Limited, Annual General Meeting, Aug 11, 2023 Jul 14
Less than half of directors are independent May 25
Full year 2023 earnings released: EPS: CN¥0.04 (vs CN¥0.02 loss in FY 2022) May 24
Alibaba Health Information Technology Limited Announces Board Changes May 17
Alibaba Health Information Technology Limited to Report Fiscal Year 2023 Final Results on May 23, 2023 May 13
Alibaba Health Information Technology Limited Provides Earnings Guidance for the Year Ended March 31, 2023 May 06
First half 2023 earnings released: EPS: CN¥0.012 (vs CN¥0.017 loss in 1H 2022) Nov 29
Alibaba Health Information Technology Limited to Report Q2, 2023 Results on Nov 28, 2022 Nov 17
Less than half of directors are independent Nov 16
Alibaba Health Information Technology Limited Provides Consolidated Earnings Guidance for the Six Months Ended September 30, 2022 Oct 27
Now 22% undervalued Jul 09
Full year 2022 earnings released: CN¥0.02 loss per share (vs CN¥0.026 profit in FY 2021) Jul 07
Alibaba Health Information Technology Limited, Annual General Meeting, Aug 05, 2022 Jul 06
Alibaba Health Information Technology Limited Announces Executive Changes Jul 01
Full year 2022 earnings released: CN¥0.02 loss per share (vs CN¥0.026 profit in FY 2021) May 26
Alibaba Health Information Technology Limited to Report Fiscal Year 2022 Final Results on May 25, 2022 May 14
Less than half of directors are independent Apr 27
Chairman of the Board & CEO recently bought €160k worth of stock Dec 10
COO & Executive Director recently bought €513k worth of stock Dec 03
First half 2022 earnings: EPS in line with expectations, revenues disappoint Nov 26
Chairman of the Board & CEO recently bought €372k worth of stock Aug 07
Full year 2021 earnings released: EPS CN¥0.026 (vs CN¥0.001 loss in FY 2020) Jul 01
Full year 2021 earnings released May 27
CFO & Executive Director recently sold €98k worth of stock Mar 23
New 90-day high: €2.95 Feb 16
New 90-day high: €2.93 Jan 23
New 90-day high: €2.57 Dec 09
New 90-day high: €2.50 Nov 10
Alibaba Health Information Technology Limited to Report First Half, 2021 Results on Nov 25, 2020 Oct 30
Non-Executive Director recently sold €752k worth of stock Sep 20
New 90-day low - €1.93 Aug 26
Alibaba Health Information Technology Limited has completed a Follow-on Equity Offering in the amount of HKD 10 billion. Aug 13
Analyse de la situation financière
Passif à court terme: Les actifs à court terme de TWY ( CN¥13.5B ) dépassent ses passifs à court terme ( CN¥5.0B ).
Passif à long terme: Les actifs à court terme de TWY ( CN¥13.5B ) dépassent ses passifs à long terme ( CN¥162.3M ).
Historique et analyse du ratio d'endettement
Niveau d'endettement: TWY est sans dette.
Réduire la dette: TWY n'a aucune dette par rapport à il y a 5 ans, lorsque son ratio d'endettement était 62.1%.
Couverture de la dette: TWY n'a pas de dette, elle n'a donc pas besoin d'être couverte par le flux de trésorerie opérationnel .
Couverture des intérêts: TWY n'a aucune dette, par conséquent la couverture des paiements d'intérêts n'est pas un problème.
Découvrir des entreprises saines Simply Wall St™ Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"control","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}